Save 20% on Press Releases and More with NNW Prime! Click to View Details
WednesdayMay 17, 2017 11:12 am

NetworkNewsBreaks – Consilium Global Research Report Projects ChineseInvestors.com, Inc. (CIIX) Will Reach $14.8M in Revenues by FY2020

A recent research report published by Consilium Global Research predicts that ChineseInvestors.com (OTCQB: CIIX) will reach revenues of $14.8 million by fiscal year 2020 and that the company will undergo a major transformation this year as it pursues a bigger stake in the cannabis market. As cited in the report, ChineseInvestors.com achieved $930,000 in revenue for FY 2016, and the company is projected to continue growing at an estimated CAGR of 100 percent through 2020, while the underlying market’s CAGR is predicted to grow at a rate of 80 percent. “Headquartered in San Gabriel, California, CIIX offers a range of…

Continue Reading

TuesdayMay 16, 2017 9:04 am

NetworkNewsBreaks – Net Element, Inc. (NASDAQ: NETE) Records 20% YOY Revenue Growth in First Quarter of 2017

Mobile payment technology company Net Element, Inc. (NASDAQ: NETE), in a news release issued late Monday, reported its financial results for the first quarter of 2017. Among the highlights, the company recorded net revenues of $13,561,941, marking a year-over-year increase of 20 percent. Net Element attributed this performance to organic growth in its North America Transaction Solutions segment, which demonstrated a year-over-year net revenue increase of 40 percent. Similarly, the company’s Online Solutions segment recorded a 23 percent year-over-year increase in revenues, which was attributed to continued organic growth in global online payment acceptance services with an emphasis on value-added…

Continue Reading

MondayMay 15, 2017 12:21 pm

NetworkNewsBreaks – Windstream (NASDAQ: WIN) Awarded 2017 Most Valuable Employers for Military®; Opens Five Fiber Routes Nationwide

Shares of Windstream’s (NASDAQ: WIN) are 6% higher on news that RecruitMilitary has awarded the company as a 2017 Most Valuable Employers (MVE) for Military®. MVEs are chosen annually based on employers that have recruiting, training and retention plans that best serve military service members and veterans. The award is marking its ninth edition in 2017. Additionally, the company said today that it is opening five strategically located fiber routes on its nationwide long-haul fiber transport network. “We are committed to welcoming veterans into our ranks because they bring experiences, technical skills and leadership attributes that make us a stronger…

Continue Reading

FridayMay 12, 2017 12:07 pm

NetworkNewsBreaks – SinglePoint, Inc. (SING) CEO Discusses Acquisition Strategy in Interview on MoneyTV

Specialized holding company SinglePoint, Inc. (OTC: SING) is a featured company on this week’s episode of MoneyTV with Donald Baillargeon. MoneyTV is an internationally syndicated television program about “money and what makes it happen.” To view the show, visit www.MoneyTV.net. In this week’s episode, SinglePoint CEO Greg Lambrecht discusses the company’s progress toward expanding its presence in the burgeoning legal marijuana industry by way of acquisition. “We’ve spent the last couple of months courting companies to acquire them, particularly in the cannabis space,” Lambrecht noted in the interview. “Actually, I think next week we’re going to be putting an LOI…

Continue Reading

ThursdayMay 11, 2017 12:50 pm

NetworkNewsBreaks – Synthesis Energy Systems, Inc. (NASDAQ: SYMX) Locks In Technology License Agreement for Project in Australia; Shares Climb

Synthesis Energy Systems (“SES”) (NASDAQ: SYMX) shares ticked 8% higher after the company said it has entered into a definitive Technology License Agreement with Australian Future Energy Pty Ltd ("AFE") for a large-scale project to be located in Australia. Per the agreement, SES will collect fees based on the licensed capacity for the project, and for the Process Design Package (PDP), totaling $27 million. Additionally, the entire package of technology, services and equipment is anticipated to provide SES with revenue of approximately $150 million. The company will immediately begin providing technical services to AFE related to the development of the…

Continue Reading

ThursdayMay 11, 2017 11:09 am

NetworkNewsBreaks – ChineseInvestors.com, Inc. (CIIX) Pursues Continued Success in CBD Markets

Leveraging its achievements of amassing a 100,000+ user base, establishing a recognizable 18-year-old brand, and sharpening its focus on a market that exceeds two billion Chinese-speaking individuals, ChineseInvestors.com (OTCQB: CIIX) has reached a first-in-the-marketplace milestone by launching the world’s first and only Chinese language, cannabinoid-based therapeutic health products web store, http://www.ChineseCBDoil.com. After making a successful investment in the marijuana market, the company recently expanded into the retail and online sale of cannabidiol (CBD), which has become one of the fastest-growing market categories in the United States. “With an annual growth rate of nearly 60 percent, CBD oil has become one…

Continue Reading

ThursdayMay 11, 2017 11:07 am

NetworkNewsBreaks – India Globalization Capital, Inc. (NYSE: IGC) Poised to Become Phytocannabinoid Pharmaceuticals Leader

At its recent 70th annual meeting, the American Epilepsy Society (AES) highlighted a study focusing on the potential of cannabidiol (CBD) to treat the frequency and severity of seizures in children who have drug-resistant epilepsies. India Globalization Capital (NYSE MKT: IGC), an innovator in developing cannabis-based combination therapies to treat pain and other conditions, is currently applying the revolutionary seizure-treating potential of CBD to another population: domestic pets, and the company is addressing the 5 percent of dogs and just over 2 percent of cats in the United States that experience seizures. “Cannabidiol is the most abundant non-psychoactive cannabinoid found…

Continue Reading

WednesdayMay 10, 2017 12:44 pm

NetworkNewsBreaks – Proteon Therapeutics, Inc.’s (NASDAQ: PRTO) Vonapanitase Receives Breakthrough Therapy Designation by FDA; Shares Soar

Proteon Therapeutics (NASDAQ: PRTO) shares are up 35% this morning on news that vonapanitase has received Breakthrough Therapy designation from the FDA. The investigational treatment received the designation for increasing arteriovenous fistula secondary patency (i.e., survival of the fistula without abandonment) and use for hemodialysis in patients on or expected to initiate hemodialysis. Secondary patency and fistula use for hemodialysis are also the co-primary endpoints of the company’s ongoing pivotal phase 3 clinical trial, PATENCY-2. Enrollment in the trial is anticipated to be complete in the first quarter of 2018, and the company expects top-line data in the first quarter…

Continue Reading

TuesdayMay 09, 2017 1:11 pm

NetworkNewsBreaks – AudioEye, Inc. (AEYE) Teams with Finalsite to Address Website Accessibility in the Education Market

AudioEye (OTCQB: AEYE) shares climbed 10% after the company said it has entered a new working agreement with Finalsite, a SaaS web solutions and digital marketing provider for the education industry. The agreement demonstrates AudioEye’s strategy to expand in the education space following its winning bid to provide web accessibility to the 99 schools within the Seattle Public School District. "The education market's reliance on electronic communications, mobile content and digital learning tools only continues to increase. We can't limit access to the Internet for students, teachers and parents with disabilities, then expect great outcomes in our schools. This partnership…

Continue Reading

TuesdayMay 09, 2017 11:54 am

NetworkNewsBreaks – Pulmatrix, Inc. (NASDAQ: PULM) Obtains Key U.S. Patent for PUR0200 to Treat COPD

Pulmatrix (NASDAQ: PULM) said today that it has received a key patent in the United States for its lead drug candidate, PUR0200, which is intended to treat chronic obstructive pulmonary diseases (COPD). PUR0200 is an inhaled drug made by combining Pulmatrix's technology platform with tiotropium bromide. The patent provides the company with intellectual property protection for the drug until 2033. The company is currently developing PUR0200 in both Europe and the United States, following regulatory pathways that offer faster approvals and decreased costs. "This new patent is another step forward to bringing PUR0200 to market—and to be able to offer…

Continue Reading

NetworkNewsWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Doge Coin

Dogecoin

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 512.354.7000